nav-left cat-right
cat-right

FLEXYTE® assays harness the power and potential of...

Melbourn, UK and Craigavon, Northern Ireland, UK (5th February 2015) – A strategic alliance has been formed for the marketing and sale of a complete fluorescence lifetime (FLT) technology comprising Almac Group’s proprietary FLEXYTE® FLT reagents and assays, and TTP Labtech’s new ameon® microplate reader. Customers can now gain full access to support, and buy equipment and essential reagents all from TTP Labtech,...

XL-protein Signs Licensing Agreement with MSD Anim...

FREISING, GERMANY, February 12, 2015 – XL-protein GmbH, Germany, a privately owned biopharmaceutical company, announced today that they have entered into a license agreement with MSD Animal Health (known as Merck Animal Health in the USA and Canada) to develop PASylated biopharmaceuticals for use in animal health. This license agreement follows a research collaboration between the two companies which began in 2012 and...

Zedira receives further funding to develop Factor ...

Zedira has received further funding from the German Federal Ministry for Education and Research (German abbreviation: BMBF). The project volume has been extended by € 1.0 Mio. so that the total project value exceeds € 5.0 Mio. by now. The additional funding will allow completing the development of a drug candidate for „safe“ anticoagulation. Zedira targets coagulation factor XIIIa (F13, plasma transglutaminase) using...

Polypropylene PCR plates from Porvair Sciences Ltd

To ensure full compatibility with robotic systems, DNase / RNase- and pyrogen-free PCR plates from Porvair Sciences feature high rigidity to minimise distortion before and after thermal cycling. Produced in Class 10,000 clean room conditions – Porvair range of PCR plates are certified free of pyrogens as well as DNAse and RNAse enzyme activity enabling routine achievement of excellent PCR results. Porvair PCR plates are...

Seegene Receives FDA Clearance for its Herpes Simp...

Gaithersburg, Maryland and SEOUL, Korea, February 17, 2015 - Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) market clearance for its TOCE™-based herpes simplex virus (HSV) types 1 and 2 assay. This is the first product that Seegene has taken through the FDA, and it opens the way for Seegene’s other...

MEDEXPO AFRICA – KENYA 2015 on 07 – 09...

Strong exhibitor line-up from over 15 countries and a comprehensive medical product, equipment & machinery showcase at Kenya’s biggest International Medical Trade Exhibition. The increasing demand for medical manufacturing products, equipment, machinery, services and solutions has prompted a surge of representation at Africa’s premier medical exhibition, MEDEXPO AFRICA – KENYA 2015. Taking place at The...

Epigenomics & Novel Therapeutic Targets Confe...

On behalf of GTCbio and the 2015 Advisory Board, you are invited the Epigenomics & Novel Therapeutic Targets Conference which takes place May 21-22, 2015 in Boston, MA. This meeting is part of The Pan-Omics Summit and focuses on transcriptional regulation, novel therapeutic targets and discoveries, pre-clinical to clinical drug development, new technological advances, and epigenomic biomarkers and diagnostics. Epigenomics...

2nd Metabolomics – Advances & Applicati...

GTCbio is proud to present the 2nd Metabolomics – Advances & Applications in Human Disease Conference, which will be part of The Pan-Omics Summit and takes place May 21-22, 2015 in Boston, MA. There is still significant human variability in metabolite identification for targets and pathways. These challenges affect the advancement in metabolomics, the use of biomarkers, and its application towards cancer, metabolic...

FMC 2015 – Frontiers in Medicinal Chemistry ...

The Frontiers in Medicinal Chemistry symposium is co-organised on a biennial basis, as a collaboration between the ACS (American Chemical Society) and the EFMC (European Federation for Medicinal Chemistry). Frontiers 2015 will take place in Antwerp, Belgium, from September 14-16, 2015. It will be jointly organised by EFMC, ACS and the local Dutch and Belgian organisers: the Medicinal and Bioorganic Chemistry Division of the...

Pharmacovigilance, Drug Safety & Risk Managem...

The expansive field of drug surveillance has increased the complexity of problems across the board in relation to PV auditing and meeting the standard requirements. Companies continue to face challenges of understanding the key considerations when presenting to auditors and knowing how to adequately adapt to different regulatory environments and changes. Moreover, clarifying individual roles within the PV system is paramount...
Page 1 of 13412345...102030...Last »